292 related articles for article (PubMed ID: 11021104)
1. [The hierarchization of the prognostic factors in uveal malignant melanoma].
Călugăru M; Mera M; Călugăru D
Oftalmologia; 2000; 50(1):30-4. PubMed ID: 11021104
[TBL] [Abstract][Full Text] [Related]
2. [A survival analysis of patients with malignant uveal melanoma].
Călugăru M; Mera M; Călugăru D
Oftalmologia; 2000; 51(2):45-51. PubMed ID: 11021123
[TBL] [Abstract][Full Text] [Related]
3. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma.
Mäkitie T; Carpén O; Vaheri A; Kivelä T
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2442-9. PubMed ID: 11581181
[TBL] [Abstract][Full Text] [Related]
4. [Intratumoral blood pools and prognosis of malignant uveal melanoma treated with enucleation].
Kantelip B; Albuisson E; Bacin F; Bonhomme R
Ophtalmologie; 1989; 3(1):49-52. PubMed ID: 2641072
[TBL] [Abstract][Full Text] [Related]
5. [Uveal malignant melanoma in Israel (1970-1989)].
Shargal Y; Pe'er J
Harefuah; 1995 Nov; 129(10):369-74, 448. PubMed ID: 8647537
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.
Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1414-21. PubMed ID: 11381040
[TBL] [Abstract][Full Text] [Related]
7. [Retrospective study of uveal melanoma].
Tóth J
Magy Onkol; 2005; 49(1):19-25. PubMed ID: 15902329
[TBL] [Abstract][Full Text] [Related]
8. Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey.
Ly LV; Odish OF; Wolff-Rouendaal Dd; Missotten GS; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):658-65. PubMed ID: 19797220
[TBL] [Abstract][Full Text] [Related]
9. Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance.
Kivelä T; Eskelin S; Mäkitie T; Summanen P
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2085-93. PubMed ID: 11481276
[TBL] [Abstract][Full Text] [Related]
10. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
[TBL] [Abstract][Full Text] [Related]
11. Update on the management of posterior uveal melanoma.
Zhao DY; Shields CL; Shields JA; Gunduz K
J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975
[TBL] [Abstract][Full Text] [Related]
12. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
13. Variates of survival in metastatic uveal melanoma.
Rietschel P; Panageas KS; Hanlon C; Patel A; Abramson DH; Chapman PB
J Clin Oncol; 2005 Nov; 23(31):8076-80. PubMed ID: 16258106
[TBL] [Abstract][Full Text] [Related]
14. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.
Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
Acta Ophthalmol; 2008 Nov; 86 Thesis 4():20-5. PubMed ID: 19032678
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
16. [Bilateral uveal melanomas. Five case reports].
Bhouri L; Lumbroso L; Levy C; Dendale R; Asselain B; Plancher C; Sastre X; Desjardins L
J Fr Ophtalmol; 2003 Feb; 26(2):149-53. PubMed ID: 12660588
[TBL] [Abstract][Full Text] [Related]
17. [The follow up of prognostic important factors and analysis of five years survival rate in patients with uveal melanoma at the Department of Ophthalmology, 3rd Medical Faculty Charles University in Prague and the Faculty Hospital Královské Vinohrady in Prague].
Redinová MV; Sach J; Baráková D; Kuchynka P; Vránová J
Cesk Slov Oftalmol; 2009 Jan; 65(1):29-35. PubMed ID: 19366035
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
[TBL] [Abstract][Full Text] [Related]
19. [The morphological forms of malignant uveal melanoma].
Simionescu C
Oftalmologia; 1993; 37(1):3-11. PubMed ID: 8507607
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
